🇺🇸 nab-paclitaxel, lobaplatin, and S-1 in United States

nab-paclitaxel, lobaplatin, and S-1 (nab-paclitaxel, lobaplatin, and S-1) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

nab-paclitaxel, lobaplatin, and S-1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is nab-paclitaxel, lobaplatin, and S-1 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for nab-paclitaxel, lobaplatin, and S-1 in United States?

Yang Jianjun, PhD is the originator. The local marketing authorisation holder may differ — check the official source linked above.